Sepsis, Phages, and COVID-19
Open Access
Abstract
Phage therapy has emerged as a potential novel treatment of sepsis for which no decisive progress has been achieved thus far. Obviously, phages can help eradicate local bacterial infection and bacteremia that may occur in a syndrome. For example, phages may be helpful in correcting excessive inflammatory responses and aberrant immunity that occur in sepsis. Data from animal studies strongly suggest that phages may indeed be an efficient means of therapy for experimentally induced sepsis. In recent years, a number of reports have appeared describing the successful treatment of patients with sepsis. Moreover, novel data on the anti-viral potential of phages may be interpreted as suggesting that phages could be used as an adjunct therapy in severe COVID-19. Thus, clinical trials assessing the value of phage therapy in sepsis, including viral sepsis, are urgently needed.Keywords
This publication has 60 references indexed in Scilit:
- Phages and ImmunomodulationFuture Microbiology, 2017
- Antiphage Activity of Sera During Phage Therapy in Relation to its OutcomeFuture Microbiology, 2016
- Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cellsVirology, 2016
- T4 Bacteriophage-Mediated Inhibition of Adsorption and Replication of Human Adenovirus in vitroFuture Microbiology, 2015
- Clinical Aspects of Phage Therapy2012
- Role of Human β-Defensin-2 during Tumor Necrosis Factor-α/NF-κB-mediated Innate Antiviral Response against Human Respiratory Syncytial VirusJournal of Biological Chemistry, 2008
- Bacteria, Phages and SepticemiaPLOS ONE, 2007
- Severe acute respiratory syndrome coronavirus 3C-like protease-induced apoptosisFEMS Immunology & Medical Microbiology, 2006
- Human β-Defensins Suppress Human Immunodeficiency Virus Infection: Potential Role in Mucosal ProtectionJournal of Virology, 2005
- Bacterial viruses against viruses pathogenic for man?Virus Research, 2005